Financial Performance - The company reported a revenue of ¥487,158,589.53 for the current period, representing a 16.04% increase compared to ¥419,817,975.73 in the same period last year[21]. - The net profit attributable to shareholders reached ¥30,105,835.02, marking a significant growth of 45.84% from ¥20,643,542.88 in the previous year[21]. - The gross profit margin improved to 15.14%, up from 13.37% year-on-year[21]. - The company achieved operating revenue of ¥487,158,589.53, representing a year-on-year growth of 16.04%[31]. - Net profit reached ¥30,105,835.02, an increase of 45.84% compared to the same period last year[31]. - The company's main business income was ¥486,332,834.27, a 16.09% increase from the previous year's ¥418,938,071.16[43]. - Total revenue for the first half of 2023 reached CNY 487,158,589.53, an increase of 15.9% compared to CNY 419,817,975.73 in the same period of 2022[106]. - Net profit for the first half of 2023 was ¥30,105,835.02, representing a 45.7% increase from ¥20,643,542.88 in the same period of 2022[108]. - Total profit for the first half of 2023 was ¥37,911,075.06, an increase of 53.2% from ¥24,744,060.36 in the first half of 2022[108]. Assets and Liabilities - Total assets increased by 20.94% to ¥620,834,723.29, compared to ¥513,354,474.43 at the end of the previous year[23]. - The company’s total liabilities decreased by 12.68% to ¥109,040,905.72, down from ¥124,873,663.00[23]. - The company's cash and cash equivalents increased by 166.34% year-on-year, reaching ¥136,614,743.44, primarily due to cash inflows from the listing on the Beijing Stock Exchange[38]. - The company's total equity attributable to shareholders at the end of the reporting period is CNY 469,398,482.97, an increase from CNY 359,958,970.30 at the end of the previous period, representing a growth of approximately 30.5%[125]. - The company reported a total of 394,745,963.34 CNY in current assets as of June 30, 2023, an increase from 276,320,436.89 CNY at the end of 2022, representing a growth of approximately 42.7%[99]. Cash Flow - The company achieved a net cash flow from operating activities of ¥16,486,921.22, a decrease of 58.98% from ¥40,193,104.16 in the prior year[24]. - Net cash flow from operating activities decreased by 58.98% to ¥16,486,921.22, primarily due to increased raw material purchases[51]. - Net cash flow from investing activities dropped by 923.84% to -¥28,633,336.61, mainly due to investments in structured deposits[51]. - Cash inflow from financing activities amounted to CNY 119,472,287.71 in the first half of 2023, with a net cash flow of CNY 97,333,571.40, compared to a net outflow of CNY 51,725,961.61 in the first half of 2022[114]. Research and Development - R&D expenses amounted to ¥8,715,181.01, accounting for 1.79% of operating revenue, supporting the company's innovation capabilities[31]. - The company's research and development expenses slightly decreased by 2.17% to ¥8,715,181.01, reflecting a focus on cost management[40]. - Research and development expenses for the first half of 2023 totaled ¥8,715,469.47, slightly down from ¥8,908,033.69 in the first half of 2022[110]. Market and Product Development - The company launched several new products at the 26th FIC China International Food Additives and Ingredients Exhibition in March 2023[2]. - The company launched new pre-prepared egg products, with revenue growth of 11.07% and a gross margin increase of 4.89 percentage points year-on-year[32]. - The company plans to launch a ready-to-drink egg white beverage in the second half of 2023, filling a market gap[33]. - The processed egg product consumption in China is only 5%-7%, indicating significant market potential compared to developed countries[35]. - The liquid egg market in China has a compound annual growth rate of 12% since 2011, highlighting growth opportunities[35]. Shareholder Information - The total number of ordinary shares increased from 153,695,536 to 205,445,536 due to the issuance of 51,750,000 new shares[74]. - The company raised a total of 129,375,000 RMB from the stock issuance at a price of 2.50 RMB per share, with a net amount of 112,822,477.86 RMB after deducting issuance costs[84]. - The largest shareholder, CHINA EGG PRODUCTS ApS, holds 135,188,506 shares, representing 65.80% of the total shares[77]. - Liu Wen, a board member and general manager, holds 10,758,692 shares, accounting for 5.24% of the total shares[77]. Corporate Governance and Compliance - The company has established a comprehensive internal control system to prevent undue influence from actual controllers on business decisions[60]. - The company has implemented strict quality control measures to address potential food safety risks, which are critical in the food production industry[60]. - The company has no significant litigation or arbitration matters reported during the reporting period[65]. - The financial report was approved by the board of directors on August 16, 2023[147]. - The financial statements comply with the latest accounting standards issued by the Ministry of Finance[150]. Employee Information - The total number of employees increased from 355 to 362, with a net addition of 7 employees during the reporting period[93]. - The company maintained a stable core employee count of 68, despite the departure of 2 core employees during the reporting period[95]. - The board of directors and senior management personnel remained unchanged during the reporting period, ensuring continuity in leadership[91]. Accounting Policies - The company did not change its accounting policies or estimates compared to the previous year's financial statements[132]. - There were no prior period errors corrected in the current financial report, indicating stability in financial reporting[132]. - The company includes all subsidiaries in its consolidated financial statements, treating the entire corporate group as a single accounting entity[166].

申万宏源证券承销保荐有限责任公司关于苏州欧福蛋业股份 截至2023年6月30日，公司募集资金使用情况具体如下： 1 二、本次募集资金投资项目名称变更基本情况 公司第三届董事会第十二次会议及第三届监事会第九次会议审议通过了《关 于变更募集资金投资项目名称的议案》，根据公司发展规划及为项目争取政策支 持的需要，公司拟将募集资金投资项目"预制蛋制品、蛋液及蛋制品生产线技术 改造项目"的项目名称变更为"氨基酸食品2500吨、生物发酵蛋白饮品6000吨、 蛋液及蛋制品40000吨、蛋制品深加工4000吨、预制蛋品2000吨、预拌粉500吨、 蛋粉400吨生产技术改造"。 三、本次变更募集资金投资项目名称对公司的影响 有限公司变更募集资金投资项目名称的核查意见 申万宏源证券承销保荐有限责任公司（以下简称"申万宏源承销保荐"或 "保荐机构"）作为苏州欧福蛋业股份有限公司（以下简称"欧福蛋业"、"公 司"）向不特定合格投资者公开发行股票并在北京证券交易所上市的保荐机构， 根据《北京证券交易所证券发行上市保荐业务管理细则》《北京证券交易所股票 上市规则（试行）》等有关法规和规范性文件的要求，对欧福蛋业变更募集资金 投资项目名称 ...

经认真审阅，我们认为，公司本次变更募集资金投资项目名称的事项符合相 关法律法规及文件要求，未改变项目的建设内容，不会影响募集资金投资项目的 正常实施，也不存在变相改变募集资金投向、损害股东利益的情形，并履行了必 要的法定程序。 证券代码：839371 证券简称：欧福蛋业 公告编号：2023-060 苏州欧福蛋业股份有限公司 独立董事关于公司第三届董事会第十二次会议相关 事项的独立意见 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担 个别及连带法律责任。 苏州欧福蛋业股份有限公司（以下简称"公司"）第三届董事会第十二次会议于 2023年8月10日召开（以下简称"本次董事会"）。作为公司的独立董事，根据《苏 州欧福蛋业股份有限公司公司章程》（以下简称"《公司章程》"）、《苏州欧福蛋业 股份有限公司独立董事工作制度》的相关规定，基于独立判断的立场，对本次董事 会审议的相关议案发表如下独立意见： 一、《关于变更募集资金投资项目名称的议案》的独立意见 因此，我们同意该议案。 苏州欧福蛋业股份有限公司 独立董事：杨严俊、吴英华、顾秦华 ...

证券代码：839371 证券简称：欧福蛋业 公告编号：2023-057 公司于 2022 年 12 月 21 日收到中国证券监督管理委员会《关于同意苏州欧 福蛋业股份有限公司向不特定合格投资者公开发行股票注册的批复》（证监许可 〔2022〕3128 号）。公司本次发行价格为 2.50 元/股，发行股数为 5,175.00 万股 （超额配售选择权行使后），募集资金总额为 129,375,000.00 元。截至 2023 年 2 月 17 日，上述募集资金已全部到账，天职国际会计师事务所（特殊普通合伙） 对本次公开发行的初始发行和行使超额配售选择权的资金到位情况进行了审验， 并分别出具了天职业字［2023］1228 号和天职业字［2023］6333 号《验资报告》。 截至 2023 年 6 月 30 日，本次募集资金使用情况具体如下： | 单位：元 | | --- | | 募集资金账户情况 | 金额（元） | | --- | --- | | 1、募集资金账户初始金额 | 119,472,287.71 | | 2、募集资金账户资金的增加项 | 98,275.51 | | 其中：利息收入 | 98,275.51 | ...

证券代码：839371 证券简称：欧福蛋业 公告编号：2023-059 （一）会议召开情况 本次会议的召集、召开、议案审议程序符合《公司法》、《公司章 程》的相关规定。 （二）会议出席情况 会议应出席监事 3 人，出席和授权出席监事 3 人。 苏州欧福蛋业股份有限公司 第三届监事会第九次会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担 个别及连带法律责任。 一、 会议召开和出席情况 1. 会议召开时间：2023 年 8 月 10 日 2. 会议召开地点：公司现场会议室 3. 会议召开方式：现场及通讯方式 4. 发出监事会会议通知的时间和方式：2023 年 8 月 2 日以书面及通 讯方式发出 5. 会议主持人：Marianne Schelde 6. 召开情况合法、合规、合章程性说明： 二、 议案审议情况 三、 备查文件目录 1. 《苏州欧福蛋业股份有限公司第三届监事会第九次会议决议》 2.议案表决结果：同意 3 票；反对 0 票；弃权 0 票。 3.回避表决情况： 本议案不涉及关联交易，无需回避表决。 本议案无需 ...

证券代码：839371 证券简称：欧福蛋业 公告编号：2023-058 苏州欧福蛋业股份有限公司 第三届董事会第十二次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担 个别及连带法律责任。 一、 会议召开和出席情况 （一）会议召开情况 本次会议的召集、召开、议案审议程序符合《公司法》及相关法 律、法规和《公司章程》、《董事会议事规则》的规定。 （二）会议出席情况 会议应出席董事 8 人，出席和授权出席董事 8 人。 1.会议召开时间：2023 年 8 月 10 日 2.会议召开地点：公司现场会议室 3.会议召开方式：现场及通讯方式 4. 发出董事会会议通知的时间和方式：2023 年 8 月 2 日以书面及通 讯方式发出 5. 会议主持人：董事长 Henrik Pedersen 6.会议列席人员：全体监事和高管 7.召开情况合法、合规、合章程性说明： 二、 议案审议情况 （一） 审议通过《关于变更募集资金投资项目名称的公告》 1.议案内容： 具体内容详见公司于同日在北京证券交易所官方信息披露平台 （http://w ...

Group 1: Company Overview and Standards - Suzhou Oufu Egg Industry Co., Ltd. is the first drafter of two national standards for egg products, effective from July 1, 2023, which will significantly impact the industry [3][5] - The implementation of these standards aims to regulate product quality and safety, enhancing market competitiveness and promoting healthy industry development [5] Group 2: Product Innovation and Development - The company emphasizes innovation-driven strategies, focusing on core technologies and product innovation around eggs [4] - The chicken protein functional drink, a new product targeting retail, is expected to launch in the second half of the year, primarily promoted through e-commerce [6][7] - Pre-made egg products, including omelets and egg skins, have seen a revenue increase of 25.11% in 2022, with sales proportion rising from 2.91% to 3.47% [8] Group 3: Market Trends and Opportunities - The pre-made egg products are positioned to benefit from the growing demand in the pre-made food industry, driven by changes in consumer habits and rising disposable incomes [8] - The company anticipates significant market opportunities as it expands its product lines and sales channels [8] Group 4: Financial Performance - In Q1 2023, the company experienced a 5.08% sales growth but a 26.68% decline in net profit due to rising raw egg prices [9] - The second quarter shows a positive operational trend, with expectations for improved performance as the market recovers [9]

证券代码：839371 证券简称：欧福蛋业 公告编号：2023-050 苏州欧福蛋业股份有限公司 关于接待机构投资者调研情况的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 苏州欧福蛋业股份有限公司（以下简称"欧福蛋业"或 "公司"）于 2023 年 5 月 15 日接待了 11 家机构的调研， 现将主要情况公告如下： 一、调研情况 调研时间：2023 年 5 月 15 日 10:00 调研地点：苏州欧福蛋业股份有限公司 调研形式：现场接待 调研机构：北京中经互联信息咨询有限责任公司；北京 祯祥投资基金管理有限公司；上海欣歌投资管理有限公司； 上海玖歌投资管理有限公司；上海珩道投资管理有限公司； 上海宝弘资产管理有限公司；中天国富证券股份有限公司； 东海证券股份有限公司；东方财富证券股份有限公司；上海 国鸣投资管理有限公司；上海乘舟投资管理有限公司。 上市公司接待人员：董事会秘书叶林 二、调研的主要问题及公司回复概要 问题 1：公司一季度利润同比有一定的下降，现在鸡蛋 涨价对公司的影响有多大？ 回 ...

证券代码：839371 证券简称：欧福蛋业 公告编号：2023-048 苏州欧福蛋业股份有限公司 2022 年年度报告业绩说明会预告公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担 个别及连带法律责任。 一、 说明会类型 苏州欧福蛋业股份有限公司（以下简称"公司"）于 2023 年 4 月 26 日在北京证券交易所信息披露平台（www.bse.cn）披露了《2022 年年度报告》（公告编号：2023-029）及《2022 年年度报告摘要》 （公告编号：2023-030），为方便广大投资者更深入了解公司 2022 年年度经营业绩的具体情况，加强与投资者的互动交流，公司拟召 开 2022 年年度报告业绩说明会。 （二）会议召开地点 本次业绩说明会将采用网络远程的方式举行，投资者可登陆全 景网"投资者关系互动平台"（https://ir.p5w.net）参与本次年报 业绩说明会。 三、 参加人员 公司董事、总经理：刘文先生 公司财务负责人：夏冰清女士 公司董事会秘书：叶林先生 公司保荐代表人：施山旭先生、刁阳炫先生 四、 投资 ...

Financial Performance - Net profit attributable to shareholders decreased by 26.68% to CNY 12,318,895.10 year-on-year[10] - Operating income rose by 5.08% to CNY 234,034,475.01 compared to the same period last year[10] - Total operating revenue for Q1 2023 reached CNY 234,034,475.01, an increase from CNY 222,712,764.90 in Q1 2022, representing a growth of approximately 5.9%[34] - Net profit for Q1 2023 was CNY 12,318,895.10, a decrease from CNY 16,802,394.72 in Q1 2022, reflecting a decline of approximately 26.7%[35] - Earnings per share for Q1 2023 were CNY 0.07, down from CNY 0.11 in Q1 2022, showing a decrease of about 36.4%[35] - Operating profit for Q1 2023 was approximately ¥7.77 million, a decline of 37.5% from ¥12.32 million in Q1 2022[37] - The company’s total comprehensive income for Q1 2023 was approximately ¥6.54 million, down from ¥10.10 million in Q1 2022[38] Assets and Liabilities - Total assets increased by 25.71% to CNY 645,352,870.50 compared to the end of last year[10] - Current assets totaled CNY 415,283,228.79, a significant increase from CNY 276,320,436.89, reflecting a growth of about 50.4%[28] - Total liabilities amounted to CNY 131,119,339.49, up from CNY 124,873,663.00, reflecting a growth of about 5.0%[29] - Total liabilities for Q1 2023 were CNY 148,552,313.67, slightly up from CNY 147,503,248.38 in Q1 2022, indicating a marginal increase of about 0.7%[32] Shareholder Information - The total equity attributable to shareholders increased by 32.37% to CNY 514,233,531.01 compared to the end of last year[10] - The company issued 51,750,000 new shares, increasing total shares to 205,445,536[15] - The company reported a total shareholding of 135,188,506 shares, representing 65.802% ownership by CHINA EGG PRODUC TS ApS as of the end of the reporting period[16] - Liu Wen holds 10,758,690 shares, accounting for 5.2368% of the total shares, making him a significant shareholder[18] - The total number of shares held by the top ten shareholders is 162,329,500, which is 79.013% of the total shares[18] Cash Flow - Cash flow from operating activities decreased by 62.55% to CNY 6,939,253.11 compared to the previous year[10] - Cash flow from financing activities increased by 432.71% to CNY 153,047,180.51 due to the issuance of shares[13] - Cash and cash equivalents rose to CNY 173,654,644.64, compared to CNY 51,292,469.09 at the end of 2022, marking an increase of approximately 238.5%[28] - Cash inflow from financing activities totaled ¥130,972,287.71, significantly up from ¥4,500,000.00 in Q1 2022[42] - Net cash flow from financing activities was ¥118,178,125.00, a turnaround from -¥30,695,745.77 in Q1 2022[42] Expenses - Management expenses increased by 49.96% to CNY 9,063,373.51 due to higher business and travel costs[12] - Financial expenses decreased by 79.40% to CNY 90,000.00 due to reduced borrowing costs[12] - Total operating costs for Q1 2023 were CNY 218,981,832.22, up from CNY 201,664,756.81 in Q1 2022, indicating an increase of about 8.6%[34] - Research and development expenses for Q1 2023 were CNY 4,275,291.56, compared to CNY 4,156,170.12 in Q1 2022, reflecting a slight increase of about 2.9%[34] Compliance and Commitments - There were no significant legal disputes or external guarantees reported during the period[21] - The company has fulfilled all previously disclosed commitments in a timely manner[21] - The financial report for Q1 2023 is not audited, and the consolidated balance sheet is presented in yuan[25][26] - There are no significant violations or misleading statements reported during the commitment period, ensuring compliance with regulatory requirements[24] Future Plans - The company is focusing on expanding its market presence and developing new products, although specific figures were not disclosed in the report[30] - The company plans to enhance its technological capabilities and explore potential mergers and acquisitions to drive future growth[30] - The company plans to continue expanding its market presence and investing in new product development to drive future growth[36]